Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs THC✓SelectedUSD · THCMRNA vs THC performance historyLatest closeAs of+1.29%11/19
Stock and ETF performance explorer

MRNA vs THC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+971.7%
THC return
+1,002.0%
Excess return
-30.3%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioTHCExcessAlpha
1D+1.3%-2.9%+4.1%+1.6%
7D-13.8%-8.1%-5.7%-13.1%
30D-17.7%-3.2%-14.5%-17.4%
3M+14.3%-1.8%+16.1%+14.5%
6M+336.0%+37.7%+298.3%+321.6%
YTD+575.9%+32.6%+543.3%+553.7%
1Y+724.4%+35.7%+688.7%+695.1%
3Y+160.8%+313.5%-152.8%+126.5%
5Y-24.4%+240.3%-264.8%-34.6%
All+971.7%+1,002.0%-30.3%+772.1%

Cumulative growth

Daily Returns

Daily percentage return beside THC.

Daily Out/Under-Performance

Portfolio return minus THC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling